TY - JOUR
T1 - Neurally adjusted ventilatory assist decreases ventilator-induced lung injury and non-pulmonary organ dysfunction in rabbits with acute lung injury
AU - Brander, Lukas
AU - Sinderby, Christer
AU - Lecomte, François
AU - Leong-Poi, Howard
AU - Bell, David
AU - Beck, Jennifer
AU - Tsoporis, James N.
AU - Vaschetto, Rosanna
AU - Schultz, Marcus J.
AU - Parker, Thomas G.
AU - Villar, Jesús
AU - Zhang, Haibo
AU - Slutsky, Arthur S.
N1 - Funding Information:
Acknowledgments We are indebted to Norman Comtois for his excellent technical assistance, to Jenna Ekborn for her invaluable help, and to the staff of the research vivarium at St. Michael’s Hospital, Toronto, for their support. The study was supported in part by the Canadian Institutes of Health Research (CIHR), the Ontario Thoracic Society (OTS), and the R. Samuel McLaughlin Foundation. Lukas Brander held postdoctoral fellowships from the Swiss National Science Foundation (SNF)/Swiss Foundation for Fellowships in Medicine and Biology (SSMBS) provided by Novartis AG (grant no. 1130) and from the Division of Respirology at the University of Toronto provided by Merck-Frosst. Marcus Schultz is supported by The Netherlands Organization for Health Research and Development (ZonMW), NWO-VENI grant 2004 (project no. 016.056.001).
PY - 2009/11
Y1 - 2009/11
N2 - Objective: To determine if neurally adjusted ventilatory assist (NAVA) that delivers pressure in proportion to diaphragm electrical activity is as protective to acutely injured lungs (ALI) and non-pulmonary organs as volume controlled (VC), low tidal volume (Vt), high positive end-expiratory pressure (PEEP) ventilation. Design: Prospective, randomized, laboratory animal study. Subjects: Twenty-seven male New Zealand white rabbits. Interventions: Anesthetized rabbits with hydrochloric acid-induced ALI were randomized (n = 9 per group) to 5.5 h NAVA (non-paralyzed), VC (paralyzed; Vt 6-ml/kg), or VC (paralyzed; Vt 15-ml/kg). PEEP was adjusted to hemodynamic goals in NAVA and VC6-ml/kg, and was 1 cmH 2O in VC15-ml/kg. Measurements and main results: PaO 2/FiO 2; lung wet-to-dry ratio; lung histology; interleukin-8 (IL-8) concentrations in broncho-alveolar-lavage (BAL) fluid, plasma, and non-pulmonary organs; plasminogen activator inhibitor type-1 and tissue factor in BAL fluid and plasma; non-pulmonary organ apoptosis rate; creatinine clearance; echocardiography. PEEP was similar in NAVA and VC6-ml/kg. During NAVA, Vt was lower (3.1 ± 0.9 ml/kg), whereas PaO 2/FiO 2, respiratory rate, and PaCO 2 were higher compared to VC6-ml/kg (p < 0.05 for all). Variables assessing ventilator-induced lung injury (VILI), IL-8 levels, non-pulmonary organ apoptosis rate, and kidney as well as cardiac performance were similar in NAVA compared to VC6-ml/kg. VILI and non-pulmonary organ dysfunction was attenuated in both groups compared to VC15-ml/kg. Conclusions: In anesthetized rabbits with early experimental ALI, NAVA is as effective as VC6-ml/kg in preventing VILI, in attenuating excessive systemic and remote organ inflammation, and in preserving cardiac and kidney function.
AB - Objective: To determine if neurally adjusted ventilatory assist (NAVA) that delivers pressure in proportion to diaphragm electrical activity is as protective to acutely injured lungs (ALI) and non-pulmonary organs as volume controlled (VC), low tidal volume (Vt), high positive end-expiratory pressure (PEEP) ventilation. Design: Prospective, randomized, laboratory animal study. Subjects: Twenty-seven male New Zealand white rabbits. Interventions: Anesthetized rabbits with hydrochloric acid-induced ALI were randomized (n = 9 per group) to 5.5 h NAVA (non-paralyzed), VC (paralyzed; Vt 6-ml/kg), or VC (paralyzed; Vt 15-ml/kg). PEEP was adjusted to hemodynamic goals in NAVA and VC6-ml/kg, and was 1 cmH 2O in VC15-ml/kg. Measurements and main results: PaO 2/FiO 2; lung wet-to-dry ratio; lung histology; interleukin-8 (IL-8) concentrations in broncho-alveolar-lavage (BAL) fluid, plasma, and non-pulmonary organs; plasminogen activator inhibitor type-1 and tissue factor in BAL fluid and plasma; non-pulmonary organ apoptosis rate; creatinine clearance; echocardiography. PEEP was similar in NAVA and VC6-ml/kg. During NAVA, Vt was lower (3.1 ± 0.9 ml/kg), whereas PaO 2/FiO 2, respiratory rate, and PaCO 2 were higher compared to VC6-ml/kg (p < 0.05 for all). Variables assessing ventilator-induced lung injury (VILI), IL-8 levels, non-pulmonary organ apoptosis rate, and kidney as well as cardiac performance were similar in NAVA compared to VC6-ml/kg. VILI and non-pulmonary organ dysfunction was attenuated in both groups compared to VC15-ml/kg. Conclusions: In anesthetized rabbits with early experimental ALI, NAVA is as effective as VC6-ml/kg in preventing VILI, in attenuating excessive systemic and remote organ inflammation, and in preserving cardiac and kidney function.
KW - Diaphragm
KW - Electromyography
KW - Multiple organ failure
KW - Respiratory distress syndrome
KW - Respiratory therapy
UR - http://www.scopus.com/inward/record.url?scp=73949156048&partnerID=8YFLogxK
U2 - 10.1007/s00134-009-1626-x
DO - 10.1007/s00134-009-1626-x
M3 - Article
SN - 0342-4642
VL - 35
SP - 1979
EP - 1989
JO - Intensive Care Medicine
JF - Intensive Care Medicine
IS - 11
ER -